Transenterix Inc (TRXC) Shares Gap Up to $2.69
Shares of Transenterix Inc (NASDAQ:TRXC) gapped up before the market opened on Thursday . The stock had previously closed at $2.77, but opened at $2.69. Transenterix shares last traded at $2.79, with a volume of 4441816 shares.
A number of analysts recently weighed in on the stock. Ladenburg Thalmann Financial Services set a $5.00 target price on shares of Transenterix and gave the stock a “buy” rating in a report on Friday, October 20th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $4.00 price objective (up previously from $3.75) on shares of Transenterix in a research note on Monday, October 30th. Finally, Zacks Investment Research lowered shares of Transenterix from a “buy” rating to a “sell” rating in a research note on Tuesday, August 8th.
In related news, insider Todd Pope sold 600,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 18th. The shares were sold at an average price of $3.68, for a total value of $2,208,000.00. Following the completion of the transaction, the insider now owns 462,644 shares of the company’s stock, valued at approximately $1,702,529.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
A number of hedge funds have recently added to or reduced their stakes in TRXC. Sabby Management LLC purchased a new stake in Transenterix in the 2nd quarter worth approximately $2,456,000. Goldman Sachs Group Inc. lifted its position in Transenterix by 7,137.7% in the 2nd quarter. Goldman Sachs Group Inc. now owns 1,203,199 shares of the company’s stock worth $854,000 after buying an additional 1,186,575 shares in the last quarter. UBS Oconnor LLC purchased a new stake in Transenterix in the 2nd quarter worth approximately $390,000. LMR Partners LLP purchased a new stake in Transenterix in the 2nd quarter worth approximately $189,000. Finally, Global X Management Co. LLC lifted its position in Transenterix by 238.3% in the 2nd quarter. Global X Management Co. LLC now owns 331,075 shares of the company’s stock worth $235,000 after buying an additional 233,213 shares in the last quarter.
TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.
Receive News & Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.